| Section | Title | Authors | Address |
|---|
|
| Genes | ACVR2A (Activin Receptor Type 2) | Boles S, Chau E, Jung B | http://atlasgeneticsoncology.org/Genes/ACVR2ID567ch2q22.html |
| Genes | ADAM23 (ADAM metallopeptidase domain 23) | Calmon MF, Rahal P | http://atlasgeneticsoncology.org/Genes/ADAM23ID44041ch2q33.html |
| Genes | ADGRE5 (CD97 molecule) | Aust G | http://atlasgeneticsoncology.org/Genes/CD97ID996ch19p13.html |
| Genes | AGAP2 (Centaurin , gamma1) | Chi Bun C, Keqiang Y | http://atlasgeneticsoncology.org/Genes/CENTG1ID44037ch12q14.html |
| Genes | AIFM1 (apoptosis-inducing factor, mitochondrion-associated, 1) | Yuste VJ, Lorenzo HK, Susin SA | http://atlasgeneticsoncology.org/Genes/AIFM1ID44053chXq25.html |
| Genes | AKAP9 (A kinase (PRKA) anchor protein (yotiao) 9) | Ciampi R, Nikiforov YE | http://atlasgeneticsoncology.org/Genes/AKAP9ID42999ch7q21.html |
| Genes | AKR1C3 (aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)) | Lin HK | http://atlasgeneticsoncology.org/Genes/AKR1C3ID612ch10p15.html |
| Genes | AKT2 (v-akt murine thymoma viral oncogene homolog 2) | Altomare DA, Testa JR | http://atlasgeneticsoncology.org/Genes/AKT2ID517ch19q13.html |
| Genes | AKT3 (v-akt murine thymoma viral oncogene homolog 3, Protein Kinase B gamma) | Cheung M, Testa JR | http://atlasgeneticsoncology.org/Genes/AKT3ID615ch1q44.html |
| Genes | ALOX12 (Arachidonate 12-Lipoxygenase) Homo sapiens | Banerjee S, Erdog A | http://atlasgeneticsoncology.org/Genes/ALOX12ID620ch17p13.html |
| Genes | ARHGEF2 (rho/rac guanine nucleotide exchange factor (GEF) 2) | Poroyko V, Birukova A | http://atlasgeneticsoncology.org/Genes/ARHGEF2ID43150ch1q22.html |
| Genes | ASCL1 (Achaete-scute homolog 1 or achaete-scute complex homolog 1) | Ladha JS, Rao MRS | http://atlasgeneticsoncology.org/Genes/ASCL1ID713ch12q23.html |
| Genes | ATF2 (activating transcription factor 2) | Lazo PA, Sevilla A | http://atlasgeneticsoncology.org/Genes/ATF2ID718ch2q31.html |
| Genes | AXIN2 (axin 2) | Hughes TA | http://atlasgeneticsoncology.org/Genes/AXIN2ID456ch17q24.html |
| Genes | BAG3 (Bcl-2 associated athanogene 3) | Leone A, Rosati A, Ammirante M, Turco MC | http://atlasgeneticsoncology.org/Genes/BAG3ID43160ch10q26.html |
| Genes | BARD1 (BRCA1 associated RING domain 1) | Irminger-Finger I | http://atlasgeneticsoncology.org/Genes/BARD1ID756ch2q35.html |
| Genes | BCL6 (B-Cell Lymphoma 6) | Knezevich S | http://atlasgeneticsoncology.org/Genes/BCL6ID20.html |
| Genes | BNIP3 (Bcl-2/adenovirus E1B 19kD-interacting protein 3) | Paik SG, Lee H | http://atlasgeneticsoncology.org/Genes/BNIP3ID822ch10q26.html |
| Genes | BRCA1 (breast cancer 1, early onset) | Banerjee S | http://atlasgeneticsoncology.org/Genes/BRCA1ID163ch17q21.html |
| Genes | BRD4 (bromodomain containing 4) | Collin A | http://atlasgeneticsoncology.org/Genes/BRD4ID837ch19p13.html |
| Genes | CARD8 (caspase recruitment domain family, member 8) | Kruyt FA | http://atlasgeneticsoncology.org/Genes/CARD8ID913ch19q13.html |
| Genes | CASP1 (caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)) | Kumar Y, Radha V, Swarup G | http://atlasgeneticsoncology.org/Genes/CASP1ID145ch11q22.html |
| Genes | CD53 (CD53 molecule) | Lazo PA | http://atlasgeneticsoncology.org/Genes/CD53ID983ch1p13.html |
| Genes | CDH1 (cadherin 1, type 1, E-cadherin (epithelial)) | Calmon MF, Rahal P | http://atlasgeneticsoncology.org/Genes/CDH1ID166ch16q22.html |
| Genes | CDK4 (cyclin-dependent kinase 4) | Molven A | http://atlasgeneticsoncology.org/Genes/CDK4ID238ch12q14.html |
| Genes | CDKN2A (cyclin dependent kinase 2a / p16) | Saffroy R, Lemoine A, Debuire B | http://atlasgeneticsoncology.org/Genes/CDKN2aID146.html |
| Genes | CTGF (connective tissue growth factor) | Kubota S, Takigawa M | http://atlasgeneticsoncology.org/Genes/CTGFID40192ch6q23.html |
| Genes | CTSH (cathepsin H) | Jevnikar Z, Kos J | http://atlasgeneticsoncology.org/Genes/CTSHID40206ch15q25.html |
| Genes | DDX43 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 43) | De Plaen E | http://atlasgeneticsoncology.org/Genes/DDX43ID40288ch6q13.html |
| Genes | DKK1 (dickkopf homolog 1 (Xenopus laevis)) | Aguilera O, Munoz A | http://atlasgeneticsoncology.org/Genes/DKK1ID44007ch10q11.html |
| Genes | DMBT1 (Deleted in malignant brain tumors 1) | Mollenhauer J, Poustka A | http://atlasgeneticsoncology.org/Genes/DMBT1ID309ch10q26.html |
| Genes | EBAG9 (Estrogen receptor-binding fragment-associated antigen 9) | Faried A, Faried LS | http://atlasgeneticsoncology.org/Genes/EBAG9ID40393ch8q23.html |
| Genes | ENC1 (ectodermal-neural cortex (with BTB-like domain)) | Avraham S, Seng S, Jiang S, Avraham HK | http://atlasgeneticsoncology.org/Genes/NRPBID40451ch5q12.html |
| Genes | ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2) | Stracke ML, Clair T | http://atlasgeneticsoncology.org/Genes/ENPP2ID40455ch8q24.html |
| Genes | ENPP7 (ectonucleotide pyrophosphatase/phosphodiesterase 7) | Duan RD | http://atlasgeneticsoncology.org/Genes/ENPP7ID44055ch17q25.html |
| Genes | EP400 (E1A binding protein p400) | Tyteca S | http://atlasgeneticsoncology.org/Genes/EP400ID40457ch12q24.html |
| Genes | EPHA7 (EPH receptor A7) | Sugimura H, Mori H, Bunai T, Suzuki M | http://atlasgeneticsoncology.org/Genes/EPHA7ID40466ch6q16.html |
| Genes | ERVW-1 (Endogenous Retroviral family W, Env (C7), member 1) | Gimenez J, Mallet F | http://atlasgeneticsoncology.org/Genes/ERVWE1ID40497ch7q21.html |
| Genes | FLCN (folliculin gene) | Schmidt LS | http://atlasgeneticsoncology.org/Genes/FLCNID789ch17p11.html |
| Genes | FNIP1 (folliculin interacting protein 1) | Schmidt LS | http://atlasgeneticsoncology.org/Genes/FNIP1ID44003ch5q23.html |
| Genes | FOXP1 (Forkhead box P1) | Wlodarska I | http://atlasgeneticsoncology.org/Genes/FOXP1ID40632ch3p14.html |
| Genes | GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type) | Radhakrishnan P, Cheng PW | http://atlasgeneticsoncology.org/Genes/GCNT3ID44105ch15q21.html |
| Genes | GLMN (Glomulin) | Aerts V, Brouillard P, Boon LM, Vikkula M | http://atlasgeneticsoncology.org/Genes/GLMNID43022ch1p22.html |
| Genes | GRB2 (Growth factor receptor-bound protein 2) | Athauda G, Bottaro DP | http://atlasgeneticsoncology.org/Genes/GRB2ID386ch17q25.html |
| Genes | GRN (Granulin) | Zhang H, Pan CX, Cheng L | http://atlasgeneticsoncology.org/Genes/GRNID40757ch17q21.html |
| Genes | HDAC3 (histone deacetylase 3) | Escaffit F | http://atlasgeneticsoncology.org/Genes/HDAC3ID40804ch5q31.html |
| Genes | HIC1 (Hypermethylated in Cancer 1) | Leprince D | http://atlasgeneticsoncology.org/Genes/HIC1ID40819ch17p13.html |
| Genes | HSPD1 (Heat Shock 60kDa Protein 1) | Faried A, Faried LS | http://atlasgeneticsoncology.org/Genes/HSPD1ID40888ch2q33.html |
| Genes | HSPH1 (heat shock 105kDa/110kDa protein 1) | Hatayama T, Yamagishi N | http://atlasgeneticsoncology.org/Genes/HSPH1ID40891ch13q12.html |
| Genes | HYAL1 (hyaluronoglucosaminidase 1) | Vynios DH | http://atlasgeneticsoncology.org/Genes/HYAL1ID40903ch3p21.html |
| Genes | HYAL2 (Hyaluronoglucosaminidase 2) | Chow LSN, Lo KW | http://atlasgeneticsoncology.org/Genes/HYAL2ID40904ch3p21.html |
| Genes | IKZF2 (IKAROS family zinc finger 2) | Sridharan R, Smale S | http://atlasgeneticsoncology.org/Genes/IKZF2ID42885ch2q34.html |
| Genes | IL6 (interleukin 6 (interferon beta 2)) | Nagel S, MacLeod RAF | http://atlasgeneticsoncology.org/Genes/IL6ID519ch7p15.html |
| Genes | ITK (IL2-inducible T-cell kinase) | Streubel B | http://atlasgeneticsoncology.org/Genes/ITKID43329ch5q33.html |
| Genes | JAG2 (Human Jagged2) | Ghoshal P, Coignet LJ | http://atlasgeneticsoncology.org/Genes/JAG2ID41030ch14q32.html |
| Genes | JAK3 (Janus Kinase 3 or Just Another Kinase 3) | Shi P, Amin HM | http://atlasgeneticsoncology.org/Genes/JAK3ID41032ch19p13.html |
| Genes | KAT5 (HIV-1 Tat interacting protein, 60kDa) | Mattera L | http://atlasgeneticsoncology.org/Genes/HTATIPID40893ch11q13.html |
| Genes | KIF14 (kinesin family member 14) | Thériault BL, Corson TW | http://atlasgeneticsoncology.org/Genes/KIF14ID44138ch1q32.html |
| Genes | KLF6 (Krüppel like factor 6) | Friedman SL, Narla G, Martignetti JA | http://atlasgeneticsoncology.org/Genes/KLF6ID44002ch10p15.html |
| Genes | KLK10 (Kallikrein-related peptidase 10) | Luo LY, Diamandis EP | http://atlasgeneticsoncology.org/Genes/KLK10ID41076ch19q13.html |
| Genes | KLRK1 (killer cell lectin-like receptor subfamily K, member 1) | Lanier LL | http://atlasgeneticsoncology.org/Genes/KLRK1ID41094ch12p13.html |
| Genes | LGI1 (Leucine-rich, Glioma Inactivated protein 1 precursor) | Gabellini N | http://atlasgeneticsoncology.org/Genes/LGI1ID311ch10q23.html |
| Genes | LINC00598 long intergenic non-protein coding RNA 598 | Huret JL | http://atlasgeneticsoncology.org/Genes/TTLID529ch13q14.html |
| Genes | LMO2 (LIM domain only 2 (rhombotin-like 1)) | Van Vlierberghe P, Huret JL | http://atlasgeneticsoncology.org/Genes/RBTN2ID34.html |
| Genes | LOXL4 (lysyl oxidase-like 4) | Szauter KM, Gorogh T, Csiszar K | http://atlasgeneticsoncology.org/Genes/LOXL4ID41193ch10q24.html |
| Genes | MAML2 (mastermind-like 2) | Suzukawa K, Huret JL | http://atlasgeneticsoncology.org/Genes/MAML2ID472.html |
| Genes | MECOM (Ecotropic Viral Integration Site 1 (EVI1) and Myelodysplastic Syndrome 1 (MDS1-EVI1) | Wieser R | http://atlasgeneticsoncology.org/Genes/EVI103q26ID19.html |
| Genes | MIR21 (microRNA 21) | Selcuklu SD, Yakicier MC, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN21ID44019ch17q23.html |
| Genes | MME (membrane metallo-endopeptidase) | Torlakovic EE | http://atlasgeneticsoncology.org/Genes/MMEID41386ch3q25.html |
| Genes | MUC16 (mucin 16, cell surface associated) | Senapati S, Ponnusamy MP, Singh AP, Jain M, Batra SK | http://atlasgeneticsoncology.org/Genes/MUC16ID41455ch19q13.html |
| Genes | MUC17 (mucin 17, cell surface associated) | Junker WM, Moniaux N, Batra SK | http://atlasgeneticsoncology.org/Genes/MUC17ID41456ch7q22.html |
| Genes | MUC4 (mucin 4, cell surface associated) | Moniaux N, Chaturvedi P, Van Seuningen I, Porchet N, Singh AP, Batra SK | http://atlasgeneticsoncology.org/Genes/MUC4ID41459ch3q29.html |
| Genes | NEIL1 (nei endonuclease VIII-like 1 (E. coli)) | Suzuki M, Shinmura K, Sugimura H | http://atlasgeneticsoncology.org/Genes/NEIL1ID41519ch15q24.html |
| Genes | NLRC4 (NLR Family, CARD domain containing 4) | Kumar Y, Radha V, Swarup G | http://atlasgeneticsoncology.org/Genes/NLRC4ID43189ch2p22.html |
| Genes | NOTCH1 (Notch homolog 1, translocation-associated (Drosophila)) | Cayo M, Greenblatt DY, Kunnimalaiyaan M, Chen H | http://atlasgeneticsoncology.org/Genes/NOTCH1ID30ch9q34.html |
| Genes | NOTCH3 (Notch homolog 3 (Drosophila)) | Wang TL | http://atlasgeneticsoncology.org/Genes/NOTCH3ID41557ch19p13.html |
| Genes | NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2) | Gabellini N | http://atlasgeneticsoncology.org/Genes/NTRK2ID41589ch9q21.html |
| Genes | NUTM1 (nuclear protein in testis) | Collin A | http://atlasgeneticsoncology.org/Genes/NUTID41595ch15q14.html |
| Genes | PAK1 (p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)) | Stepanova D, Chernoff J | http://atlasgeneticsoncology.org/Genes/PAK1ID41633ch11q13.html |
| Genes | PAWR (PRKC apoptosis WT1 regulator protein; Prostate apoptosis response-4, Par-4) | Zhao Y, Rangnekar V | http://atlasgeneticsoncology.org/Genes/PAWRID41641ch12q21.html |
| Genes | PDCD4 (Programmed Cell Death 4) | Colburn NH | http://atlasgeneticsoncology.org/Genes/PDCD4ID41675ch10q24.html |
| Genes | PEBP1 (phosphatidylethanolamine binding protein 1) | Beach S, Yeung KC | http://atlasgeneticsoncology.org/Genes/PEBP1ID44021ch12q24.html |
| Genes | PLAGL1 (Pleomorphic adenoma gene-like 1) | Abdollahi A | http://atlasgeneticsoncology.org/Genes/PLAGL1ID41737ch6q24.html |
| Genes | PLCB2 (phospholipase C, beta 2) | Bertagnolo V, Brugnoli F, Benedusi M, Capitani S | http://atlasgeneticsoncology.org/Genes/PLCB2ID41743ch15q15.html |
| Genes | POU4F1 (POU class 4 homeobox 1) | Budhram-Mahadeo V, Latchman DS | http://atlasgeneticsoncology.org/Genes/POU4F1ID44173ch13q31.html |
| Genes | PPM1D (protein phosphatase 1D magnesium-dependent, delta isoform) | Bulavin D, Demidov O | http://atlasgeneticsoncology.org/Genes/PPM1DID41803ch17q23.html |
| Genes | PPP1R1B (protein phosphatase 1, regulatory (inhibitor) subunit 1B (dopamine and cAMP regulated phosphoprotein, DARPP-32)) | El-Rifai W, Belkhiri A | http://atlasgeneticsoncology.org/Genes/PPP1R1BID44096ch17q12.html |
| Genes | PRKAB1 (protein kinase, AMP-activated, beta 1 non-catalytic subunit) | Sanchez-Cespedes M | http://atlasgeneticsoncology.org/Genes/PRKAB1ID44100ch12q24.html |
| Genes | PSIP1 (PC4 and SFRS1 interacting protein 1) | Morerio C, Panarello C | http://atlasgeneticsoncology.org/Genes/PSIP1ID405ch9q22.html |
| Genes | PTGS2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG | http://atlasgeneticsoncology.org/Genes/PTGS2ID509ch1q31.html |
| Genes | PTHLH (parathyroid hormone-like hormone) | Yeung SCJ | http://atlasgeneticsoncology.org/Genes/PTHLHID41897ch12p11.html |
| Genes | RAC3 (ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)) | Heisterkamp NC | http://atlasgeneticsoncology.org/Genes/RAC3ID42022ch17q25.html |
| Genes | RACK1 (receptor for activated C kinase 1) | Mourtada-Maarabouni M | http://atlasgeneticsoncology.org/Genes/GNB2L1ID43285ch5q35.html |
| Genes | RAF1 (v-raf-1 murine leukemia viral oncogene homolog 1) | Cayo M, Greentblatt DY, Kunnimalaiyaan M, Chen H | http://atlasgeneticsoncology.org/Genes/RAF1ID42032ch3p25.html |
| Genes | RARRES1 (retinoic acid receptor responder (tazarotene induced) 1) | Lo KW, Chung GTY | http://atlasgeneticsoncology.org/Genes/RARRES1ID42050ch3q25.html |
| Genes | RBM5 (RNA binding motif protein 5) | Mourtada-Maarabouni M | http://atlasgeneticsoncology.org/Genes/RBM5ID42069ch3p21.html |
| Genes | RHOA (ras homolog gene family, member A) | Gomez del Pulgar T, Lacal JC | http://atlasgeneticsoncology.org/Genes/RHOAID42107ch3p21.html |
| Genes | RHOB (ras homolog gene family, member B) | Huang M, Laury-Kleintop LD, Prendergast G | http://atlasgeneticsoncology.org/Genes/RHOBID42108ch2p24.html |
| Genes | RHOC (ras homolog gene family, member C) | Faried A, Faried LS | http://atlasgeneticsoncology.org/Genes/RHOCID42110ch1p13.html |
| Genes | RMRP (RNA component of mitochondrial RNA processing endoribonuclease) | Hermanns P, Reicherter K, Lee B | http://atlasgeneticsoncology.org/Genes/RMRPID44001ch9p21.html |
| Genes | RNASET2 (ribonuclease T2) | Campomenosi P, Acquati F | http://atlasgeneticsoncology.org/Genes/RNASET2ID518ch6q27.html |
| Genes | RNF7 (RING finger protein-7) | Sun Y | http://atlasgeneticsoncology.org/Genes/RNF7ID44108ch3q22.html |
| Genes | RTN4 (reticulon 4) | Yutsudo M | http://atlasgeneticsoncology.org/Genes/RTN4ID42182ch2p16.html |
| Genes | S100B (S100 calcium binding protein B) | Fernandez-Fernandez MR, Fersht AR | http://atlasgeneticsoncology.org/Genes/S100BID42195ch21q22.html |
| Genes | SAV1 (Salvador homolog 1 (Drosophila)) | Callus BA | http://atlasgeneticsoncology.org/Genes/SAV1ID42206ch14q13.html |
| Genes | SEPT2 (septin 2) | Cerveira N, Teixeira MR | http://atlasgeneticsoncology.org/Genes/SEPT2ID44125ch2q37.html |
| Genes | SNCG (synuclein, gamma (breast cancer-specific protein 1)) | Czekierdowski A, Czekierdowska S | http://atlasgeneticsoncology.org/Genes/SNCGID42343ch10q23.html |
| Genes | SOCS1 (Suppressor of cytokine signaling 1) | Lin LI, Tien HF | http://atlasgeneticsoncology.org/Genes/SOCS1ID42350ch16p13.html |
| Genes | SOCS2 (suppressor of cytokine signaling 2) | Fernández-Pérez L, Flores-Morales A | http://atlasgeneticsoncology.org/Genes/SOCS2ID44123ch12q21.html |
| Genes | SPA17 (sperm autoantigenic protein 17) | Faried LS, Faried A | http://atlasgeneticsoncology.org/Genes/SPA17ID42360ch11q24.html |
| Genes | SPINK7 (serine peptidase inhibitor, Kazal type 7 (putative)) | Yu X, Lu SH | http://atlasgeneticsoncology.org/Genes/SPINK7ID40396ch5q33.html |
| Genes | STARD13 (StAR-related lipid transfer (START) domain containing 13) | Leung THY, Yam JWP, Ng IOL | http://atlasgeneticsoncology.org/Genes/STARD13ID44051ch13q13.html |
| Genes | STK11 (serine/threonine kinase 11) | Bapat B, Perera S | http://atlasgeneticsoncology.org/Genes/STK11ID292.html |
| Genes | TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) | Wu J, Han B | http://atlasgeneticsoncology.org/Genes/TNFRSF6BID42628ch20q13.html |
| Genes | TNFSF10 (tumor necrosis factor (ligand) superfamily, member 10) | di Iasio MG, Melloni E, Secchiero P, Capitani S | http://atlasgeneticsoncology.org/Genes/TNFSF10ID42632ch3q26.html |
| Genes | TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) | Olivier M | http://atlasgeneticsoncology.org/Genes/P53ID88.html |
| Genes | VRK1 (Vaccinia-related kinase 1) | Lazo PA, Vega FM, Sevilla A, Valbuena A, Sanz-Garcia M, Lopez-Sanchez I, Blanco S | http://atlasgeneticsoncology.org/Genes/VRK1ID43556ch14q32.html |
| Genes | WWOX (WW domain containing oxidoreductase) | Druck T, Hagrass H, Huebner K | http://atlasgeneticsoncology.org/Genes/WWOXID508ch16q23.html |
| Genes | ZFP36L1 (Zinc finger protein 36, C3H type-like 1) | Stumpo DJ, Blackshear PJ | http://atlasgeneticsoncology.org/Genes/ZFP36L1ID42866ch14q22.html |
| Genes | ZNF384 (Zinc Finger protein 384) | Gorello P, La Starza R, Mecucci C | http://atlasgeneticsoncology.org/Genes/ZNF384ID42881ch12p13.html |
| Leukemias | T-lineage acute lymphoblastic leukemia (T-ALL) | Raimondi SC | http://atlasgeneticsoncology.org/Anomalies/TALLID1374.html |
| Leukemias | del(11)(p12p13) LMO2 | Van Vlierberghe P, Meijerink JPP | http://atlasgeneticsoncology.org/Anomalies/del11p12p13ID1351.html |
| Leukemias | dic(1;15)(p11;p11) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0115p11p11ID1159.html |
| Leukemias | i(8)(q10) in acute myeloid leukaemia | Betts D | http://atlasgeneticsoncology.org/Anomalies/i8q10ID1334.html |
| Leukemias | inv(11)(p15q22) NUP98/DDX10 | Morerio C, Panarello C | http://atlasgeneticsoncology.org/Anomalies/inv11p15q22ID1116.html |
| Leukemias | inv(11)(q21q23) KMT2A/MAML2 in therapy related leukemias | Suzukawa K | http://atlasgeneticsoncology.org/Anomalies/inv11q21q23ID1471.html |
| Leukemias | inv(3)(p12q26) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv3p12q26ID1275.html |
| Leukemias | inv(3)(q23q26) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv3q23q26ID1276.html |
| Leukemias | t(12;13)(p13;q12) ETV6/FLT3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1213p13q12ETV6FLT3ID1495.html |
| Leukemias | t(12;13)(p13;q14) LIN00598/ETV6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1213p13q14ID1323.html |
| Leukemias | t(12;17)(p13;q11) TAF15/ZNF384 | Gorello P, La Starza R, Mecucci C | http://atlasgeneticsoncology.org/Anomalies/t1217p13q11ID1369.html |
| Leukemias | t(12;19)(p13;p13) TCF3/ZNF384 | Gorello P, La Starza R, Mecucci C . | http://atlasgeneticsoncology.org/Anomalies/t1219p13p13ID1460.html |
| Leukemias | t(12;22)(p13;q12) EWSR1/ZNF384 | Gorello P, La Starza R, Mecucci C . | http://atlasgeneticsoncology.org/Anomalies/t1222p13q12ID1371.html |
| Leukemias | t(1;21)(p35;q22) RUNX1/YTHDF2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0121p35q22ID1447.html |
| Leukemias | t(1;21)(q21;q22) RUNX1/ZNF687 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0121q21q22ID1446.html |
| Leukemias | t(1;9)(q24;q34) RCSD1/ABL1 | De Braekeleer E, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/t0109q24q34ID2109.html |
| Leukemias | t(2;11)(q37;q23) KMT2A/SEPT2 | Correia C, Teixeira MR | http://atlasgeneticsoncology.org/Anomalies/t0211q37q23ANLLID1457.html |
| Leukemias | t(2;13)(p16;q12) SPTBN1/FLT3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0213p16q12ID1212.html |
| Leukemias | t(2;19)(p11;p13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0219p11p13ID1288.html |
| Leukemias | t(3;11)(q26;p15) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0311q26p15ID1474.html |
| Leukemias | t(3;12)(q26;q21) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0312q26q21ID1280.html |
| Leukemias | t(3;17)(q26;q22) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0317q26q22ID1282.html |
| Leukemias | t(3;18)(q26;q11) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0318q26q11ID1283.html |
| Leukemias | t(3;3)(p24;q26) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0303p24q26ID1277.html |
| Leukemias | t(3;4)(p21;q34) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0304p21q34ID1433.html |
| Leukemias | t(3;5)(q26;q34) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0305q26q34ID1278.html |
| Leukemias | t(3;6)(q25;q26) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0306q25q26ID1211.html |
| Leukemias | t(3;8)(q26;q24) PVT1/MECOM | Lin P | http://atlasgeneticsoncology.org/Anomalies/t0308q26q24ID1463.html |
| Leukemias | t(3;9)(q26;p23) ?/MECOM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0309q26p23ID1279.html |
| Leukemias | t(4;11)(q35;q23) KMT2A/SORBS2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0411q35q23ID1423.html |
| Leukemias | t(4;17)(q12;q21) FIP1L1/RARA | Buijs A, Bruin M | http://atlasgeneticsoncology.org/Anomalies/t0417q12q21ID1470.html |
| Leukemias | t(4;21)(q31;q22) RUNX1/SH3D19 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0421q31q22ID1448.html |
| Leukemias | t(5;12)(q31;p13) ETV6/ACSL6 in MDS,AML and AEL | Odero MD | http://atlasgeneticsoncology.org/Anomalies/t0512q31p13ID1344.html |
| Leukemias | t(5;9)(q33;q22) ITK/SYK | Berthold Streubel B | http://atlasgeneticsoncology.org/Anomalies/t0509q33q22ID1458.html |
| Leukemias | t(6;11)(q13;q23) KMT2A/SMAP1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0611q13q23ID1408.html |
| Leukemias | t(6;7)(q23;q34) TRB/MYB and AHI1 | Clappier E, Soulier J | http://atlasgeneticsoncology.org/Anomalies/t0607q23q34ID1465.html |
| Leukemias | t(6;8)(q27;p12) FGFR1OP/FGFR1 | Vizmanos JL | http://atlasgeneticsoncology.org/Anomalies/t68ID1090.html |
| Leukemias | t(7;21)(p22;q22) RUNX1/USP42 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0721p22q22ID1449.html |
| Leukemias | t(7;9)(q11;p13) PAX5/ELN | Bousquet M, Dastugue N, Brousset P | http://atlasgeneticsoncology.org/Anomalies/t0709q11p13ID1195.html |
| Leukemias | t(8;12)(p12;p11) FGFR1OP2/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0812p12p11ID1330.html |
| Leukemias | t(8;12)(q24;q22) BTG1/MYC | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0812q24q22ID2057.html |
| Leukemias | t(8;17)(p11;q23) MYO18A/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0817p12q23ID1387.html |
| Leukemias | t(9;11)(p22;p15) NUP98/PSIP1 | Morerio C, Panarello C | http://atlasgeneticsoncology.org/Anomalies/t0911p22p15ID1232.html |
| Leukemias | t(9;21)(p22;q22) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Bone: Subungual exostosis with t(X;6)(q13;q22) COL4A5/COL12A1 | Storlazzi CT, Mertens F | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Colon: Colorectal adenocarcinoma | Sayar N, Banerjee S | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Gallbladder: Carcinoma of the gallbladder and extrahepatic bile ducts | Enjoji M, Kaku T | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Head and Neck: Pleomorphic salivary gland adenoma with ins(8)(q12;q11q11) TCEA1/PLAG1 | Asp J, Stenman G | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Head and Neck: Pleomorphic salivary gland adenoma with inv(8)(q12q12) CHCHD7/PLAG1 | Asp J, Stenman G | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Liver: Combined hepatocellular and cholangiocarcinoma | Enjoji M, Aishima S | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Midline Carcinoma: t(15;19)(q14;p13) BRD4/NUTM1 | Collin A | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Nervous System: Neurofibroma | Kluwe L, Hagel C, Mautner V | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Nervous system: Embryonal tumors: Neuroblastoma | Ambros IM, Speleman F, Ambros PF | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Nervous system: Trisomy 19 ependymoma | Godfraind C, Vikkula M | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Skin: Melanoma | Castori M, Grammatico P | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Soft Tissues: Deep (aggressive) angiomyxoma | Micci F, Brandal P | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Soft Tissues: Alveolar soft part sarcoma with t(X;17)(p11;q25) ASPSCR1/TFE3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Soft Tissues: Synovial sarcoma with t(X;20)(p11;q13) SS18L1/SSX1 | Storlazzi CT, Mertens F | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Thyroid: Anaplastic (undifferentiated) carcinoma | Yeung SCJ | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Thyroid: Papillary Carcinoma with inv(7)(q21q34) AKAP9/BRAF | Ciampi R, Nikiforov YE | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Solid Tumors | Uterine corpus : Uterus: Leiomyoma | Lynch AM, Morton CC | http://atlasgeneticsoncology.org/Anomalies/t0921p22q22ID1304.html |
| Cancer-Prones | Cartilage-hair hypoplasia (CHH) | Hermanns P, Lee B | http://atlasgeneticsoncology.org/Kprones/CartilageHairHypoID10105.html |
| Cancer-Prones | Congenital myofibromatosis | Zand DJ, Zackai EH | http://atlasgeneticsoncology.org/Kprones/CongMyofibromID10137.html |
| Cancer-Prones | Currarino syndrome | Lynch SA | http://atlasgeneticsoncology.org/Kprones/CurrarinoID10082.html |
| Cancer-Prones | Diamond-Blackfan anemia (DBA) | Gazda HT | http://atlasgeneticsoncology.org/Kprones/DiamondBlackfanID10040.html |
| Cancer-Prones | Frasier syndrome (FS) | Cajaiba MM, Reyes-Múgica M | http://atlasgeneticsoncology.org/Kprones/FrasierID10035.html |
| Cancer-Prones | Glomuvenous malformation (GVM) | Aerts V, Brouillard P, Boon LM, Vikkula M | http://atlasgeneticsoncology.org/Kprones/GlomuvenousID10120.html |
| Cancer-Prones | Hemihyperplasia isolated | Phadke SR | http://atlasgeneticsoncology.org/Kprones/HemihyperplasiaID10046.html |
| Cancer-Prones | Holoprosencephaly-diencephalic hamartoblastoma (HDH). | Castori M, Grammatico P | http://atlasgeneticsoncology.org/Kprones/HoloDienHamartoID10142.html |
| Cancer-Prones | Pallister Hall syndrome (PHS) | Johnston JJ, Biesecker LG | http://atlasgeneticsoncology.org/Kprones/PallisterHallID10126.html |
| Cancer-Prones | Weaver syndrome | Piccione M, Corsello G | http://atlasgeneticsoncology.org/Kprones/WeaverID10141.html |
| Deep Insights | A role of actin-to-CD95 connection in CD-95 apoptotic pathway | Brambilla D, Lozupone F, Fais S | http://atlasgeneticsoncology.org/Deep/CD95ApoptoPathwayID20060.html |
| Deep Insights | Genetic Instability in Cancer | Perera S, Bapat B | http://atlasgeneticsoncology.org/Deep/GenetInstabilityCancerID20056.html |
| Educational Items | How human chromosome aberrations are formed | Schinzel A | http://atlasgeneticsoncology.org/Educ/ChromAberFormedID30065ES.html |
